-
公开(公告)号:US09775906B2
公开(公告)日:2017-10-03
申请号:US12485192
申请日:2009-06-16
IPC分类号: A61K47/10 , A61K31/196 , A61K31/405 , A61K31/4422 , A61K31/4458 , A61K31/496 , A61K31/573 , A61K31/58 , A61K9/06 , A61K31/445 , A61K9/00
CPC分类号: A61K47/10 , A61K9/0019 , A61K9/0048 , A61K9/0051 , A61K9/06 , A61K31/196 , A61K31/405 , A61K31/4422 , A61K31/445 , A61K31/4458 , A61K31/496 , A61K31/573 , A61K31/58
摘要: Some aspects of this disclosure relate to a method of treating an opthalmic disease affecting an eye of a patient comprising forming a covalently-crosslinked hydrogel in situ at a peri-ocular, intra-ocular, or intra-vitreal site for controlled release of a therapeutic agent.
-
公开(公告)号:US09125807B2
公开(公告)日:2015-09-08
申请号:US11825848
申请日:2007-07-09
IPC分类号: A61K47/10 , A61K9/00 , A61K31/196 , A61K31/405 , A61K31/4422 , A61K31/4458 , A61K31/496 , A61K31/573 , A61K31/58
CPC分类号: A61K47/10 , A61K9/0019 , A61K9/0048 , A61K9/0051 , A61K9/06 , A61K31/196 , A61K31/405 , A61K31/4422 , A61K31/445 , A61K31/4458 , A61K31/496 , A61K31/573 , A61K31/58
摘要: Some aspects of this disclosure relate to a method of treating an opthalmic disease affecting an eye of a patient comprising forming a covalently-crosslinked hydrogel in situ at a peri-ocular, intra-ocular, or intra-vitreal site for controlled release of a therapeutic agent.
摘要翻译: 本公开的一些方面涉及治疗影响患者眼睛的眼科疾病的方法,包括在眼周,眼内或玻璃体外部位置原位形成共价交联的水凝胶,以控制释放治疗 代理商
-
公开(公告)号:US07862538B2
公开(公告)日:2011-01-04
申请号:US12012606
申请日:2008-02-04
IPC分类号: A61M37/00
CPC分类号: A61B17/0057 , A61B2017/00495 , A61B2017/0065
摘要: Described herein are systems for packaging dual or multiple-component adhesive systems that provide enhanced convenience and efficacy. In one aspect, the components of such a system may be divided into containers that allow for foolproof mixing schemes to avoid mixing the wrong components while also providing a sterile surface for mixing materials, with the sterile surface having optimal physical properties for mixing the materials, especially in small amounts. Certain embodiments include a surgical delivery system for a medical sealant including a packaging system with a detachable a sterile surface for mixing the sealant as needed for application.
摘要翻译: 本文描述的是用于包装双组分或多组分粘合剂体系的系统,其提供增强的便利性和有效性。 在一个方面,这种系统的组件可以被分成容器,其允许防混合方案以避免混合错误的组分,同时还提供用于混合材料的无菌表面,无菌表面具有用于混合材料的最佳物理性质, 特别是少量。 某些实施方案包括用于医用密封剂的手术递送系统,其包括具有可拆卸无菌表面的包装系统,用于根据需要混合密封剂。
-
公开(公告)号:US20090252781A1
公开(公告)日:2009-10-08
申请号:US12485192
申请日:2009-06-16
IPC分类号: A61F2/00 , A61K9/10 , A61K38/00 , A61K31/7088
CPC分类号: A61K47/10 , A61K9/0019 , A61K9/0048 , A61K9/0051 , A61K9/06 , A61K31/196 , A61K31/405 , A61K31/4422 , A61K31/445 , A61K31/4458 , A61K31/496 , A61K31/573 , A61K31/58
摘要: Some aspects of this disclosure relate to a method of treating an opthalmic disease affecting an eye of a patient comprising forming a covalently-crosslinked hydrogel in situ at a peri-ocular, intra-ocular, or intra-vitreal site for controlled release of a therapeutic agent.
摘要翻译: 本公开的一些方面涉及治疗影响患者眼睛的眼科疾病的方法,包括在眼周,眼内或玻璃体外部位置原位形成共价交联的水凝胶,以控制释放治疗 代理商
-
公开(公告)号:US20090198177A1
公开(公告)日:2009-08-06
申请号:US12012606
申请日:2008-02-04
IPC分类号: A61M37/00
CPC分类号: A61B17/0057 , A61B2017/00495 , A61B2017/0065
摘要: Certain embodiments include a surgical delivery system for a medical sealant including a packaging system with a detachable a sterile surface for mixing the sealant as needed for application.
摘要翻译: 某些实施方案包括用于医用密封剂的手术递送系统,其包括具有可拆卸的无菌表面的包装系统,用于根据需要混合密封剂。
-
公开(公告)号:US20090017097A1
公开(公告)日:2009-01-15
申请号:US11825848
申请日:2007-07-09
IPC分类号: A61K9/10 , A61K31/7088 , A61K9/127 , A61P27/00 , A61K38/00
CPC分类号: A61K47/10 , A61K9/0019 , A61K9/0048 , A61K9/0051 , A61K9/06 , A61K31/196 , A61K31/405 , A61K31/4422 , A61K31/445 , A61K31/4458 , A61K31/496 , A61K31/573 , A61K31/58
摘要: Some aspects of this disclosure relate to a method of treating an opthalmic disease affecting an eye of a patient comprising forming a covalently-crosslinked hydrogel in situ at a peri-ocular, intra-ocular, or intra-vitreal site for controlled release of a therapeutic agent.
摘要翻译: 本公开的一些方面涉及治疗影响患者眼睛的眼科疾病的方法,包括在眼周,眼内或玻璃体外部位置原位形成共价交联的水凝胶,以控制释放治疗 代理商
-
-
-
-
-